In CRC mouse models, Roseburia intestinalis or butyrate reduces tumorigenesis, restores gut barrier integrity, and activates cytotoxic CD8+ T cells via Toll-like receptor 5 (TLR5) binding and NF-κB signaling. The gene discussed is CD8A; the disease is colorectal carcinoma.